Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 17 pseudogene 4 (RBM17P4) is a genomic DNA region classified as a *pseudogene* of the *RNA binding motif protein 17 (RBM17)* gene[2]. Unlike its parent gene RBM17, which encodes a splicing factor protein involved in mRNA splicing, RBM17P4 does not produce a functional protein and lacks evidence of biological or therapeutic relevance. There are no known protein products, functions, or disease associations attributed to RBM17P4 in current scientific resources[2]. **Key distinctions**: - RBM17 is an active, protein-coding gene involved in mRNA splicing, with alternative names including SPF45[1][5]. - RBM17P4 is a *pseudogene*: it is a non-functional copy related to RBM17, without evidence of expression or utility as a drug target[2]. Given the above, RBM17P4 should not be considered a drug discovery target, receptor, enzyme, transporter, or a molecule of therapeutic interest.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 17 pseudogene 4 (RBM17P4).